Clarivate PLC (New York Stock Exchange:CLVT)
| Market Cap | 940.31M-60.6% |
| Revenue (ttm) | 2.41B-3.5% |
| Net Income | -334.00M+22.9% |
| EPS | -0.52+16.3% |
| Shares Out | 639.66M |
| PE Ratio | n/a |
| Forward PE | 1.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,239,375 |
| Open | 1.47 |
| Previous Close | 1.47 |
| Day's Range | 1.42 - 1.49 |
| 52-Week Range | 1.42 - 3.87 |
| Beta | 1.40 |
| Analysts | Hold |
| Price Target | 2.00(+36.05%) |
| Earnings Date | Nov 3, 2026 |
CLARIVATE PLC has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
About CLVT
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CLVT stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CLVT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CLVT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CLVT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CLVT Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Recurring Revenues | $512.60M | 46.60% |
| Subscription revenues | $403.30M | 36.67% |
| Re-occurring Revenues | $109.30M | 9.94% |
| Transactional and other revenues | $74.70M | 6.79% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CLVT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CLVT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CLVT
| ETF | Est. Holding Size |
|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | $23.39M |
| IWMiShares Russell 2000 ETF | $13.59M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $10.88M |
| VXFVanguard Extended Market ETF | $10.21M |
| VTWOVanguard Russell 2000 ETF | $4.12M |
| DFATDimensional - US Targeted Value ETF | $3.82M |
Estimated from each fund’s disclosed top holdings × AUM
CLVT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CLVT’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score